Literature DB >> 19421226

Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia.

P P Piccaluga, E Sabattini, F Bacci, C Agostinelli, S Righi, F Salmi, N Testoni, S Paolini, F Castagnetti, G Martinelli, B Falini, S A Pileri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19421226     DOI： 10.1038/leu.2009.95

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

Review 1.  Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.

Authors:  Susan Branford; Dennis Dong Hwan Kim; Jane F Apperley; Christopher A Eide; Satu Mustjoki; S Tiong Ong; Georgios Nteliopoulos; Thomas Ernst; Charles Chuah; Carlo Gambacorti-Passerini; Michael J Mauro; Brian J Druker; Dong-Wook Kim; Francois-Xavier Mahon; Jorge Cortes; Jerry P Radich; Andreas Hochhaus; Timothy P Hughes
Journal:  Leukemia       Date:  2019-06-17       Impact factor: 11.528

2.  Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.

Authors:  Sergej Konoplev; C Cameron Yin; Steven M Kornblau; Hagop M Kantarjian; Marina Konopleva; Michael Andreeff; Gary Lu; Zhuang Zuo; Rajyalakshmi Luthra; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Leuk Lymphoma       Date:  2012-07-09

3.  Coexpression Pattern Analysis of NPM1-Associated Genes in Chronic Myelogenous Leukemia.

Authors:  Fengfeng Wang; Lawrence W C Chan; Nancy B Y Tsui; S C Cesar Wong; Parco M Siu; S P Yip; Benjamin Y M Yung
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

4.  A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression.

Authors:  George Giotopoulos; Louise van der Weyden; Hikari Osaki; Alistair G Rust; Paolo Gallipoli; Eshwar Meduri; Sarah J Horton; Wai-In Chan; Donna Foster; Rab K Prinjha; John E Pimanda; Daniel G Tenen; George S Vassiliou; Steffen Koschmieder; David J Adams; Brian J P Huntly
Journal:  J Exp Med       Date:  2015-08-24       Impact factor: 14.307

5.  ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia.

Authors:  J Menezes; R N Salgado; F Acquadro; G Gómez-López; M C Carralero; A Barroso; F Mercadillo; L Espinosa-Hevia; J G Talavera-Casañas; D G Pisano; S Alvarez; J C Cigudosa
Journal:  Blood Cancer J       Date:  2013-11-08       Impact factor: 11.037

Review 6.  NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.

Authors:  Gianfranco Catalano; Pasquale Niscola; Cristina Banella; Daniela Diverio; Malgorzata Monika Trawinska; Stefano Fratoni; Rita Iazzoni; Paolo De Fabritiis; Elisabetta Abruzzese; Nelida Ines Noguera
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.